top of page

HEK293/Human EP1 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0196A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


EP1, officially known as PTGER1, is one of the four G protein-coupled receptors for prostaglandin E2 (PGE2). It is primarily distributed in the kidneys, lungs, gastrointestinal smooth muscle, as well as the central nervous system and sensory neurons. Functionally, upon activation, the EP1 receptor primarily acts by increasing intracellular calcium ion concentration. It is involved in pain perception (particularly inflammatory pain), febrile response, smooth muscle contraction, and regulating renal water and salt excretion. Consequently, the EP1 receptor is considered a potential drug target for treating inflammatory pain and cardiovascular diseases.

 

Screeningbio’s HEK293/Human EP1 cell line overexpress PTGER1 receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal. 

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

EP1

Accession Number

NM_000955 (Hs)

Parental Line

HEK293

Lot#

See Vial

Storage

Liquid Nitrogen


Data


HEK293/Human EP1 Agonist Assay. HEK293/Human EP1 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
HEK293/Human EP1 Agonist Assay. HEK293/Human EP1 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


EP1, officially known as PTGER1, is one of the four G protein-coupled receptors for prostaglandin E2 (PGE2). It is primarily distributed in the kidneys, lungs, gastrointestinal smooth muscle, as well as the central nervous system and sensory neurons. Functionally, upon activation, the EP1 receptor primarily acts by increasing intracellular calcium ion concentration.


It is involved in pain perception (particularly inflammatory pain), febrile response, smooth muscle contraction, and regulating renal water and salt excretion. Consequently, the EP1 receptor is considered a potential drug target for treating inflammatory pain and cardiovascular diseases.


Product Documentation



bottom of page